ISDS Case Map
health
A massive trade pact between 12 Pacific rim countries could limit the availability of affordable medicines, the head of the World Health Organization said
Now that the whole text of the TPPA has been released, it appears the TPPA provides many avenues for the tobacco industry to thwart and frustrate government efforts to enact stronger measures.
The vacuous “tobacco control” provision in the Trans Pacific Partnership (TPP) virtually capitulates to the demands of multinational tobacco corporations, jeopardizing nations’ health and economic welfare.
There is a paucity of information on drug prices, revenues and other relative information on the economics of the pharmaceutical market.
Writing pharmaceutical regulations into international trade deals can have costly consequences.
Ahead of a meeting between Indian Prime Minister Modi and German Chancellor Merkel this week, European manufacturers had already protested India’s patents policy, arguing that it doesn’t protect sensitive technology.
EU trade deals with Canada and the US could endanger citizens’ rights to basic services like water and health, as negotiators are doing the work of some of the EU’s most powerful corporate lobby groups in pushing an aggressive market opening agenda in the public sector.
The TPP’s intellectual property chapter represents nothing less than a disaster for global health. Many harmful provisions still remain in the final chapter, bearing out the concerns of public health advocates.
The TPP could give pharmaceutical corporations more power to control medicine markets and “impose higher prices for longer.”
TPP, like other Free Trade Agreements (FTAs), is fashioned by industrial countries and their transnational corporations to further intensify the concentration of resources, wealth, and power into their hands leaving developing countries.
